A PHASE 1, OPEN-LABEL, SINGLE-DOSE MASS BALANCE AND METABOLITE PROFILING STUDY OF 14C-LABELED IZICOPAN (INF904) IN HEALTHY MALE PARTICIPANTS
INF904-P1.2
Phase 1 other active
Quick answer
A PHASE 1, OPEN-LABEL, SINGLE-DOSE MASS BALANCE AND METABOLITE PROFILING STUDY OF 14C-LABELED IZICOPAN (INF904) IN HEALTHY MALE PARTICIPANTS for Not applicable, healthy volunteers is a Phase 1 program (other) at InflaRx GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- InflaRx GmbH
- Indication
- Not applicable, healthy volunteers
- Phase
- Phase 1
- Modality
- other
- Status
- active